Use of CD134 As a Primary Receptor by the Feline Immunodeficiency Virus

Science

Volumn 303, Issue 5661, 2004, Pages 1192-1195

  Shimojima, Masayuki ^a   Miyazawa, Takayuki ^b,c   Ikeda, Yasuhiro ^d   McMonagle, Elizabeth L ^e   Haining, Hayley ^e   Akashi, Hiroomi ^a   Takeuchi, Yasuhiro ^d   Hosie, Margaret J ^e   Willett, Brian J ^e  

^a UNIVERSITY OF TOKYO   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; DISEASES; IMMUNOLOGY; PROTEINS;

COSTIMULATORY MOLECULES; VIRAL RECEPTORS;

VIRUSES;

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CD134 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COMPLEMENTARY DNA; HETEROCYCLIC COMPOUND; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RECEPTOR;

VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN EXPRESSION; ARTICLE; CAT; CAT DISEASE; CELL LINE; CELL STRAIN 3T3; CHEMISTRY; CONTROLLED STUDY; EVOLUTION; FELINE IMMUNODEFICIENCY VIRUS; GENE LIBRARY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; MOLECULAR GENETICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRIORITY JOURNAL; SPECIES DIFFERENCE; SYNCYTIUM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL LINE; VIROLOGY; VIRUS INFECTION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; CATS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; DNA, COMPLEMENTARY; GENE LIBRARY; HELA CELLS; HETEROCYCLIC COMPOUNDS; HIV; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; RECEPTORS, CXCR4; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, VIRUS; SPECIES SPECIFICITY; TRANSDUCTION, GENETIC; TRANSFECTION;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

EID: 1242351765     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1092124     Document Type: Article

References (30)

1. Q. J. Sattentau, R. A. Weiss, Cell 52, 631 (1988).
2. E. A. Berger, P. M. Murphy, J. M. Farber, Annu. Rev. Immunol. 17, 657 (1999).
3. P. D. Kwong et al., Nature 393, 648 (1998).
4. R. W. Doms, J. P. Moore, J. Cell Biol. 151, F9 (2000).
5. N. C. Pedersen, E. W. Ho, M. L. Brown, J. K. Yamamoto, Science 235, 790 (1987).
6. N. C. Pedersen, in The Retroviridae, J. A. Levy, Ed. (Plenum, New York, 1993), vol. 2, chap. 3.
7. A. deParseval, J. H. Elder, J. Virol. 75, 4528 (2001).
8. B. J. Willett, M. J. Hosie, J. C. Neil, J. D. Turner, J. A. Hoxie, Nature 385, 587 (1997).
9. J. Richardson et al., J. Virol. 73, 3661 (1999).
10. T. Miyazawa et al., Arch. Virol. 108, 131 (1989).
11. M. Shimojima et al., Anal. Biochem. 315, 138 (2003).
12. D. J. Paterson et al., Mol. Immunol. 24, 1281 (1987).
13. S. Mallett, S. Fossum, A. N. Barclay, EMBO J. 9, 1063 (1990).
14. M. J. Endres et al., Cell 87, 745 (1996).
15. M. J. Hosie et al., J. Virol. 72, 2097 (1998).
16. B. J. Willett et al., J. Virol. 71, 6407 (1997).
17. B. J. Willett et al., J. Virol. 72, 6475 (1998).
18. A. Al Shamkhani et al., Eur. J. Immunol. 26, 1695 (1996).
19. E. Stuber, W. Strober, J. Exp. Med. 183, 979 (1996).
20. I. Gramaglia, A. D. Weinberg, M. Lemon, M. Croft, J. Immunol. 161, 6510 (1998).
21. P. R. Baum et al., EMBO J. 13, 3992 (1994).
22. H. Durkop, U. Latza, P. Himmelreich, H. Stein, Br. J. Haematol. 91, 927 (1995).
23. R. V. English, C. M. Johnson, D. H. Gebhard, M. B. Tompkins, J. Virol. 67, 5175 (1993).
24. G. A. Dean, G. H. Reubel, P. F. Moore, N. C. Pedersen, J. Virol. 70, 5165 (1996).
25. B. J. Willett, C. A. Cannon, M. J. Hosie, J. Virol. 77, 709 (2003).
26. D. L. Lerner, J. H. Elder, J. Virol. 74, 1854 (2000).
27. C. C. Bleul, L. Wu, J. A. Hoxie, T. A. Springer, C. R. Mackay, Proc. Natl. Acad. Sci. U.S.A. 94, 1925 (1997).
28. L. Wu et al., J. Exp. Med. 185, 1681 (1997).
29. M. J. Hosie, R. Osborne, G. Reid, J. C. Neil, O. Jarrett, Vet. Immunol. Immunopathol. 35, 191 (1992).
30. Supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology and by PRESTO, Japan Science and Technology Agency (T.M.); NIH grant RO1 AI49765-01A1 (E.M., M.J.H., and B.J.W.); The Wellcome Trust (M.J.H. and H.H.); Japan Society for the Promotion of Science (M.S.); and the Medical Research Council (Y.T.) and Cancer Research UK (Y.I.). We are grateful to R. A. Weiss for critical evaluation of the manuscript, A. N. Barclay for the provision of antisera, and N. Ishii for the human OX40 cDNA.